These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 24530737)
1. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737 [TBL] [Abstract][Full Text] [Related]
2. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497 [TBL] [Abstract][Full Text] [Related]
3. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer. Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837 [TBL] [Abstract][Full Text] [Related]
4. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma. Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724 [TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471 [TBL] [Abstract][Full Text] [Related]
6. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression. Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598 [TBL] [Abstract][Full Text] [Related]
7. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819 [TBL] [Abstract][Full Text] [Related]
9. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer. Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951 [TBL] [Abstract][Full Text] [Related]
10. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075 [TBL] [Abstract][Full Text] [Related]
11. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer. Rosanò L; Bagnato A J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335 [TBL] [Abstract][Full Text] [Related]
12. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer. Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550 [TBL] [Abstract][Full Text] [Related]
13. Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells. Rosanò L; Cianfrocca R; Bagnato A Methods Mol Biol; 2019; 1957():393-406. PubMed ID: 30919368 [TBL] [Abstract][Full Text] [Related]
14. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process. Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204 [TBL] [Abstract][Full Text] [Related]
15. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer. Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway. Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551 [TBL] [Abstract][Full Text] [Related]
17. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227 [TBL] [Abstract][Full Text] [Related]